Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Investors Should Avoid C3.ai Stock for Now

By Chris Lau, InvestorPlace Contributor

C3.ai did not rally much alongside the Nasdaq; that's a bearish sign which investors should take seriously instead of ignoring.

Avoid Plug Power Stock at All Costs

By Chris Lau, InvestorPlace Contributor

Plug Power’s financial results restatement is a serious management blunder and will send the stock spiraling lower.

Airbnb Is So Much More Than Just Hot Air as Tourism Ramps Up

By Chris Lau, InvestorPlace Contributor

ABNB stock is in an uptrend because investors expect its technology advancements to widen its moat.

Why Sundial Has To Prove Its Worth to Hopeful Investors

By Chris Lau, InvestorPlace Contributor

SNDL stock is still a trader’s favorite as the cannabis sector runs hot and cold, but Sundial must prove its worth in 2021.

7 5G Stocks Keeping an Eye on Huawei

By Chris Lau, InvestorPlace Contributor

As Huawei gets shut out of global markets, competing 5G stocks have a chance to grow their market share at an accelerated rate.

Load More